ClinicalTrials.gg
RecruitingNCT06679543Updated Apr 28, 2026

Effects of Partial Sleep Deprivation on Cardiac Output During Cycling

An interventional study of Partial sleep deprivation in Sleep Deprivation, sponsored by University of Guelph. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by University of Guelph · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The goal of this clinical trial is to determine if attenuations in cardiac output drive the blunted blood pressure response during cycling exercise following a night of partial sleep deprivation in young healthy adults (%50 females). The secondary outcome is to assess sex differences. The main questions it aims to answer are:

  • Do reductions in plasma volume drive reductions in cardiac output and therefore blood pressure during exercise following a night of partial sleep deprivation?
  • Do sex differences exist?

Participants will:

  • Visit the lab after a night of normal sleep and a night of partial sleep deprivation.
  • Keep a daily diary of their sleep and food/beverage intake.
  • Perform maximal and submaximal exercise on a cycle ergometer.
Read the detailed description

The investigators recently published data showing systolic blood pressure is attenuated during cycling exercise in males but not females following acute partial sleep deprivation, compared to a night of normal sleep, despite no differences in power output. The mechanisms responsible for this sex difference remain unknown. The investigators have pilot data that suggests males have a reduction in cardiac output following acute partial sleep deprivation, but females do not. Therefore, the primary purpose of this study is to assess hemodynamics (blood pressure, stroke volume, and cardiac output) and plasma volume during cycling exercise following a night of normal sleep and partial sleep deprivation in otherwise healthy males and females.

Thirty young healthy adults (50% female) will be recruited to undergo three visits. The first visit will assess maximal oxygen uptake to determine aerobic fitness and metabolic exercise intensity zones. The following two testing visits will be randomized and will be completed after a night of normal sleep or acute partial sleep deprivation (early awakening, 40% normal sleep duration). Sleep will be measured 1-week before each visit subjectively (questionnaire) to determine habitual sleep timing and duration and objectively (wrist actigraphy) the night before each testing visit. Each testing visit will require participants to complete a constant load 60-minute bout of cycling. Before, during, and after the exercise protocol, the investigators will measure hemodynamics and plasma volume. Venous blood samples will be collected via intravenous lines.

02

Conditions studied

  • Sleep Deprivation

Browse trials for

Keywords

  • exercise blood pressure
  • cardiac output
  • plasma volume
  • sleep deprivation
03

In context

Sleep Deprivation

314 studies on the registry are indexed under Sleep Deprivation; 59 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 259 interventional studies indexed under Sleep Deprivation.

Browse Sleep Deprivation studies →

Lead sponsor

University of Guelph is the lead sponsor of 70 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Free of known cardiovascular or metabolic diseases or sleep disorders
  • No history of smoking (within the past 3 months)
  • Able to engage in physical activity assessed through the physical activity readiness questionnaire (PAR-Q+)
  • No prescription of chronic medications other than oral
  • Able to abide by sleep protocols for all visits
  • Individuals who are not allergic to ultrasound gel
  • Individuals who are not pregnant

Exclusion criteria

Exclusion Criteria:

  • Individuals diagnosed with cardiovascular or metabolic disease or sleep disorders
  • Has a history of smoking (within the past 3 months)
  • Not ready to engage in physical activity as assessed by the PAR-Q+
  • Individuals prescribed chronic medications other than oral
  • Unable to abide by sleep protocols for any testing visit
  • Allergic to ultrasound gel
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • No intervention
    Normal sleep

    During this arm, participants will be asked to come to the lab for testing after a night of normal sleep. Normal sleep will be defined as participants habitual sleep-wake timing.

  • Experimental
    Partial sleep deprivation

    During this arm, participants will be asked to come to the lab for testing after a night of partial sleep deprivation. Participants will be asked to fall asleep at their habitual bedtime but wake up early (\~40% of normal sleep duration).

    Other: Partial sleep deprivation

Interventions

  • OtherPartial sleep deprivation

    Participants will be asked to come to the lab for testing after a night of partial sleep deprivation. Participants will be asked to fall asleep at their habitual bedtime but wake up early (\~40% of normal sleep duration).

06

What researchers measure

Primary outcomes

  1. cardiac output responses to cycling exercise

    Cardiac output during exercise after a night of normal sleep and after a night of partial sleep deprivation

    Time frame: Comparison between normal sleep and partial sleep deprivation, ~3 weeks

Secondary outcomes

  1. Blood pressure responses to cycling exercise

    Blood pressure during exercise after a night of normal sleep and after a night of partial sleep deprivation

    Time frame: Comparison between normal sleep and partial sleep deprivation, ~3 weeks

  2. Plasma volume

    Plasma volume after a night of normal sleep and after a night of partial sleep deprivation

    Time frame: Comparison between normal sleep and partial sleep deprivation, ~3 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — IPD used in the results publication

Time frame: Beginning after publication with no end date

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

Of 141 non-industry interventional studies with no phase under Sleep Deprivation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 23 months is above that.

Counting every sponsor, half of 150 studies reached it within 17 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2024
First posted
Nov 7, 2024
StartActual
Jan 2, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Apr 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06679543
Lead sponsor
University of Guelph
Responsible party
Philip Millar (Associate Professor, University of Guelph) — Principal investigator
First posted
Nov 7, 2024
Start date
Jan 2, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 28, 2026

Study contacts

Julian Bommarito, MSc
Contact
jbomma01@uoguelph.ca
9052209829
Julian Bommarito, MSc
study director · University of Guelph
Philip Millar, PhD
principal investigator · University of Guelph

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion